ArticleFrontiers in pharmacology2022

Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition.

Jianyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.